5T5G (SETD8) Citations (2)
Originally described in: SGC Toronto Q2 Q3 2016Unpublished
Articles Citing 5T5G (SETD8)
| Articles |
|---|
| An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer. Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, Azidis-Yates E, Vassiliadis D, Bell CC, Gilan O, Jackson S, Tan L, Wong SQ, Hollizeck S, Michalak EM, Siddle HV, McCabe MT, Prinjha RK, Guerra GR, Solomon BJ, Sandhu S, Dawson SJ, Beavis PA, Tothill RW, Cullinane C, Lehner PJ, Sutherland KD, Dawson MA. Cancer Cell. 2019 Oct 14;36(4):385-401.e8. doi: 10.1016/j.ccell.2019.08.008. Epub 2019 Sep 26. PubMed |
| DMSO-Related Effects on Ligand-Binding Properties of Lysine Methyltransferases G9a and SETD8. Feoli A, Sarno G, Castellano S, Sbardella G. Chembiochem. 2024 Feb 16;25(4):e202300809. doi: 10.1002/cbic.202300809. Epub 2024 Jan 25. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.